SMSPHARMA
SMS Pharmaceuticals
Each stock's 10,000-path forecast, rendered as light.
SMS Pharmaceuticals (SMSPHARMA) Stock Analysis & Case Study
Is SMSPHARMA a good buy? The data-driven verdict.
on the numbers it mixed signals, a Downstox Snapshot Score of 45/100.
On the numbers, SMS Pharmaceuticals (SMSPHARMA) mixed signals, a Downstox Snapshot Score of 45/100, weighing a 60% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
SMSPHARMA share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of SMSPHARMA history (25%/yr drift, 50%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SMSPHARMA 2027 | ₹227 | ₹427 | ₹819 | +13% |
| SMSPHARMA 2028 | ₹197 | ₹491 | ₹1,223 | +30% |
| SMSPHARMA 2029 | ₹187 | ₹553 | ₹1,666 | +46% |
| SMSPHARMA 2030 | ₹180 | ₹620 | ₹2,245 | +64% |
| SMSPHARMA 2031 | ₹171 | ₹706 | ₹2,948 | +87% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SMSPHARMA goes up, or doubles?
The bull case for SMSPHARMA
- SMS Pharmaceuticals is part of the NSE universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,666.
The bear case & risks
- High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹187.
SMSPHARMA volatility & expected range, how bumpy is the ride?
Over the last 2.0 years SMSPHARMA compounded at 25%/year with annualized volatility of 50%. That volatility implies a 1-year 80% range of ₹227–₹819, the honest backbone behind any single price target.
SMSPHARMA price forecast, the full 60-month probability fan
SMSPHARMA price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SMSPHARMA hits common targets within the simulated horizon?
Full multi-horizon detail on the SMSPHARMA price target & forecast page.
SMSPHARMA MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy SMSPHARMA with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| UpstoxCHEAPEST | 37.5% | 2.7× |
| ZerodhaCHEAPEST | 37.5% | 2.7× |
| DhanCHEAPEST | 37.5% | 2.7× |
Compare every broker on the SMSPHARMA MTF page.
SMSPHARMA vs peers,sector comparison
About SMS Pharmaceuticals: sector, index & market-cap context
SMS Pharmaceuticals (SMSPHARMA) is an NSE-listed company.
How the SMSPHARMA Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of SMS Pharmaceuticals's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SMSPHARMA analysis, FAQs
Is SMS Pharmaceuticals (SMSPHARMA) a good buy?
On the numbers, SMS Pharmaceuticals (SMSPHARMA) mixed signals, a Downstox Snapshot Score of 45/100, weighing a 60% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SMSPHARMA overvalued or undervalued?
Valuation ratios for SMSPHARMA are tracked live on Downstox.
What is the SMSPHARMA share price target for 2031?
SMSPHARMA's probability-weighted 2031 median target is ₹706, with an 80% range of ₹171–₹2,948 (10,000-path Monte-Carlo).
What is the probability SMSPHARMA doubles in 5 years?
The modelled probability of SMSPHARMA reaching ₹757 (2×) within 5 years is 47%.
What is the bull case for SMSPHARMA?
SMS Pharmaceuticals is part of the NSE universe with live, tracked fundamentals on Downstox.
What are the risks in SMSPHARMA?
High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.